ICROTOXIN has long been used as a tool for eliciting cardiac arrhythmias through activation of the central nervous system.1)-4) Although sympathetic and parasympathetic mechanisms are both implicated in this model, enhanced central sympathetic outflow to the heart and adrenally released catecholamines play a dominant role in the genesis of cardiac arrhythmias.2), 3) The activation of adrenoceptors in coronary arteries and on cardiac cells provided a cellular basis for the genesis of arrhythmias. Alpha-adrenoceptor activation results in coronary vasoconstriction, which may cause cardiac ischemic changes and promote the occurrence of cardiac arrhythmias.4) Activation of alpha-and beta-adrenoceptors on cardiac cells produces cyclic-AMP-independent and cyclic-AMP-dependent increases in slow inward currents, respectively.5) Increases in slow inward currents may lead to the accumulation of intracellular calcium. Calcium overload plays an important role in the genesis of cardiac arrhythmias in several conditions, including increased catecholamine release.6)-9) The release of calcium overload with calcium-channel blockers should block those types of arrhythmias. Therefore, experiments were performed to assess the effect of calcium-channel blockers on picrotoxininduced arrhythmias.
MATERIALS AND METHODS
Seventy-two cats of either sex weighing 1.6 to 3.3kg were anesthetized with chloralose, 40mg/kg, i.p. All cats were cannulated with endotracheal tubes and artificially ventilated with room air. The end expiratory CO2 concentration was maintained at 3.5-4.5%. They were immobilized with pancuronium bromide, initially with 0.08mg/kg followed by 0.02mg/kg i.v. every 20-40min. The femoral vein and artery were catheterized for drug administration and blood pressure monitoring, respectively. In some experiments polyethylene tubes (Intramedic) were inserted into the vertebral artery or advanced via the left femoral artery through the aorta into the left ventricle for intravertebral or intracardiac injections of nifedipine. The blood pressure was monitored with a Gould P23ID transducer connected to an amplifier. Heart rate was monitored with a Gould Biotach triggered by arterial pulses. The lead II electrocardiogram (ECG) was monitored by a Gould universal preamplifier and displayed continuously on a Tektronix 922 oscilloscope. Note that all the values shown were collected at stabilized maximal changes after administration of respective agents. 
